Ovarian cancer: how can resistance to chemotherapy be tackled?
Author:
Affiliation:
1. Gene Expression & Regulation Program, The Wistar Institute, PA 19104, USA
2. Department of Cellular & Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033, USA
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon-2017-0235
Reference20 articles.
1. Cancer statistics, 2017
2. Ovarian cancer: strategies for overcoming resistance to chemotherapy
3. Cancer immunotherapy comes of age
4. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
5. Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway;Phytomedicine;2023-01
2. Arborinine suppresses ovarian cancer development through inhibition of LSD1;Life Sciences;2022-02
3. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells;Archives of Gynecology and Obstetrics;2020-11-05
4. Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer;Cancer Cell International;2020-07-16
5. Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis;Scientific Reports;2020-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3